Inwound ApS: Financial statements 2021
CVR: 39766612
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Inwound ApS (CVR 39766612) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -856,634 and a net result of DKK -2,151,165 compared with DKK -508,153 the year before. Equity in the 2021 report amounted to DKK -2,244,825. The company had 3 employees in the financial year.
- Gross Profit
- DKK -856,634
- Profit/Loss
- DKK -2,151,165
- Equity
- DKK -2,244,825
- Total Assets
- DKK 4,279,508
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -857 t. | -2.2 mio. | -2.2 mio. | 3 |
| 2020 | - | -72 t. | -508 t. | -1.1 mio. | 2 |
Official annual report
Find more companies like Inwound ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Inwound ApS has published its annual report for 2020. Gross profit came to DKK -72,275, and the net result was DKK -508,153.
As of June 15, 2021, Bjørn Broby Glavind has joined the board of directors of Inwound ApS.
About Inwound ApS
Inwound ApS is a Danish company of the type Anpartsselskab based in Vanløse, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named VulCur MedTech ApS. The management consists of Lasse Blirup Snejbjerg. The board consists of Carl Morten Bilbo (chair), Bent von Eitzen, Christopher Bromley and Lasse Blirup Snejbjerg. The company's owners include WINDING ROADS ApS, Akk Biotek Holding ApS and K Fischer Hansen ApS. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK -4,096,380 and a net result of DKK -7,706,800 compared with DKK -1,025,932 the year before. Equity in the 2025 report amounted to DKK 5,862,914.